Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Hepatitis C virus infection: a risk factor for Parkinson's disease.

Wu WY, Kang KH, Chen SL, Chiu SY, Yen AM, Fann JC, Su CW, Liu HC, Lee CZ, Fu WM, Chen HH, Liou HH.

J Viral Hepat. 2015 Oct;22(10):784-91. doi: 10.1111/jvh.12392. Epub 2015 Jan 21.

PMID:
25608223
2.

Hepatitis C virus infection as a risk factor for Parkinson disease: A nationwide cohort study.

Tsai HH, Liou HH, Muo CH, Lee CZ, Yen RF, Kao CH.

Neurology. 2016 Mar 1;86(9):840-6. doi: 10.1212/WNL.0000000000002307. Epub 2015 Dec 23.

PMID:
26701382
3.

Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.

Aimé P, Sun X, Zareen N, Rao A, Berman Z, Volpicelli-Daley L, Bernd P, Crary JF, Levy OA, Greene LA.

J Neurosci. 2015 Jul 29;35(30):10731-49. doi: 10.1523/JNEUROSCI.0614-15.2015.

4.

A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.

Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H.

Int J Epidemiol. 1998 Aug;27(4):574-8.

PMID:
9758109
5.

Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.

Fisicaro P, Valdatta C, Massari M, Loggi E, Ravanetti L, Urbani S, Giuberti T, Cavalli A, Vandelli C, Andreone P, Missale G, Ferrari C.

Gastroenterology. 2012 Dec;143(6):1576-1585.e4. doi: 10.1053/j.gastro.2012.08.041. Epub 2012 Aug 25.

PMID:
22929808
6.

Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?

Hartmann A, Michel PP, Troadec JD, Mouatt-Prigent A, Faucheux BA, Ruberg M, Agid Y, Hirsch EC.

J Neurochem. 2001 Mar;76(6):1785-93.

7.

Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China.

Hsing AW, Zhang M, Rashid A, McGlynn KA, Wang BS, Niwa S, Ortiz-Conde BA, Goedert JJ, Fraumeni JF Jr, O'Brien TR, Gao YT.

Int J Cancer. 2008 Apr 15;122(8):1849-53.

8.

Evidence for association between hepatitis C virus and Parkinson's disease.

Abushouk AI, El-Husseny MWA, Magdy M, Ismail A, Attia A, Ahmed H, Pallanti R, Negida A.

Neurol Sci. 2017 Nov;38(11):1913-1920. doi: 10.1007/s10072-017-3077-4. Epub 2017 Aug 5. Review.

PMID:
28780707
9.

Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4-phenylpyridinium-induced neurotoxicity.

Hung SY, Liou HC, Kang KH, Wu RM, Wen CC, Fu WM.

Mol Pharmacol. 2008 Dec;74(6):1564-75. doi: 10.1124/mol.108.048611. Epub 2008 Sep 17.

10.

Clinical significance of occult hepatitis B virus infection in chronic hepatitis C patients.

Jang JY, Jeong SW, Cheon SR, Lee SH, Kim SG, Cheon YK, Kim YS, Cho YD, Kim HS, Jin SY, Kim YS, Kim BS.

Korean J Hepatol. 2011 Sep;17(3):206-12. doi: 10.3350/kjhep.2011.17.3.206.

11.

Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes.

Chen PS, Peng GS, Li G, Yang S, Wu X, Wang CC, Wilson B, Lu RB, Gean PW, Chuang DM, Hong JS.

Mol Psychiatry. 2006 Dec;11(12):1116-25. Epub 2006 Sep 12.

PMID:
16969367
12.
13.

Chronic hepatitis C virus infection: it is not only about the liver.

Vigani AG, Tozzo R, Quezada A, Diaz AC, Mendes L, Lopes I, Riberio E, Espindola GM, Lopes FP, Petoilho EC, Queiroz JL, Castro HM.

Eur J Gastroenterol Hepatol. 2014 Mar;26(3):313-8. doi: 10.1097/MEG.0b013e328362dbff.

PMID:
23719563
14.

Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication.

Huang JF, Dai CY, Hwang SJ, Ho CK, Hsiao PJ, Hsieh MY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Shin SJ, Chang WY, Chuang WL, Yu ML.

Am J Gastroenterol. 2007 Jun;102(6):1237-43.

PMID:
17531012
15.

Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responses.

Moorman JP, Zhang CL, Ni L, Ma CJ, Zhang Y, Wu XY, Thayer P, Islam TM, Borthwick T, Yao ZQ.

Vaccine. 2011 Apr 12;29(17):3169-76. doi: 10.1016/j.vaccine.2011.02.052. Epub 2011 Mar 3.

16.

HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010-12: a retrospective observational cohort study.

Zhang F, Zhu H, Wu Y, Dou Z, Zhang Y, Kleinman N, Bulterys M, Wu Z, Ma Y, Zhao D, Liu X, Fang H, Liu J, Cai WP, Shang H.

Lancet Infect Dis. 2014 Nov;14(11):1065-1072. doi: 10.1016/S1473-3099(14)70946-6. Epub 2014 Oct 7.

PMID:
25303841
17.

Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?

Damier P, Kastner A, Agid Y, Hirsch EC.

Neurology. 1996 May;46(5):1262-9.

PMID:
8628464
18.

Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms.

Fu SP, Wang JF, Xue WJ, Liu HM, Liu BR, Zeng YL, Li SN, Huang BX, Lv QK, Wang W, Liu JX.

J Neuroinflammation. 2015 Jan 17;12:9. doi: 10.1186/s12974-014-0230-3.

19.

Hepatitis C virus infection is a risk factor for tumor recurrence after resection of small hepatocellular carcinomas.

Huo TI, Wu JC, Hsia CY, Chau GY, Lui WY, Huang YH, Lee PC, Chang FY, Lee SD.

World J Surg. 2004 Aug;28(8):787-91. Epub 2004 Aug 3.

PMID:
15457359
20.

[Relations between IL-2-330 polymorphisms and the outcome of hepatitis B and/or hepatitis C virus infection].

Gao QJ, Liu DW, Zhang SY, Wu LH, Jia M.

Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Sep;31(9):1041-5. Chinese.

PMID:
21162873

Supplemental Content

Support Center